Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 75,699Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8McCarthy Tétrault

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Pomalidomide

Brand Name : POMALYST

Patent Number : 2261762

Filing Date : 1997-07-24

Strength per Unit : 1 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2017-07-24

Date Granted : 2008-06-17

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Pomalidomide

Brand Name : POMALYST

Patent Number : 2752550

Filing Date : 2010-05-19

Strength per Unit : 1 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-05-19

Date Granted : 2014-07-15

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Pomalidomide

Brand Name : POMALYST

Patent Number : 2261762

Filing Date : 1997-07-24

Strength per Unit : 2 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2017-07-24

Date Granted : 2008-06-17

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Pomalidomide

Brand Name : POMALYST

Patent Number : 2752550

Filing Date : 2010-05-19

Strength per Unit : 2 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-05-19

Date Granted : 2014-07-15

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Pomalidomide

Brand Name : POMALYST

Patent Number : 2261762

Filing Date : 1997-07-24

Strength per Unit : 3 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2017-07-24

Date Granted : 2008-06-17

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Pomalidomide

Brand Name : POMALYST

Patent Number : 2752550

Filing Date : 2010-05-19

Strength per Unit : 3 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-05-19

Date Granted : 2014-07-15

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Pomalidomide

Brand Name : POMALYST

Patent Number : 2261762

Filing Date : 1997-07-24

Strength per Unit : 4 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2017-07-24

Date Granted : 2008-06-17

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Pomalidomide

Brand Name : POMALYST

Patent Number : 2752550

Filing Date : 2010-05-19

Strength per Unit : 4 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-05-19

Date Granted : 2014-07-15

blank